Verve Therapeutics Inc (NASDAQ:VERV) traded at $11.11 at close of the session on Monday, June 23 and made an upward move of 0.45%% on its previous day’s price.
Looking at the stock we see that its previous close was $11.06 and the beta (5Y monthly) reads 1.675 with the day’s price range being $11.04 – $11.19. In terms of its 52-week price range, VERV has a high of $11.40 and a low of $2.86. The company’s stock has gained about 162.65% over that past 30 days.
Verve Therapeutics Inc has a market cap of $990.38 million and is expected to release its quarterly earnings report on 2025-May-14.
On the other hand, looking at the outlook for the VERV stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 8 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 2 have rated the Verve Therapeutics Inc (VERV) stock as a Hold, while 5 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 69.51% off its SMA20 and 104.24% from its 50-day simple moving average. The RSI (14) is pointing at 84.86 while the volatility over the past week is 30.23% and jumps to 13.58% over the past one month. The average price target for the stock over the next 12 months is $15, with the estimates having a low of $15 and a high of $15. These price ends are -35.01% and -35.01% off the current price level respectively, although investors could be excited at the prospect of a -35.01% if the VERV share price touches on the median price of $15.
Coming back to Verve Therapeutics Inc (NASDAQ:VERV), we note that the average 3-month trading volume was 5.12 million, while that of the preceding 10-day period stands at 12.4 million. Current shares outstanding are 88.80 million.
The insiders hold 26.23% of the company’s shares while institutions hold 74.01%. The data shows that short shares as of 2025-05-30, stood at 19.84 million at a short ratio of 6.99. This represents a 2637.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 18.51 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 117.84% up in year-to-date price movement.
